Phase II randomized trial of early versus late vaccination in patients with high risk CLL.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Leukaemia vaccine; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 03 May 2012 Biomarkers information updated
- 02 May 2012 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.